CandlesenseCandlesense
News/Companies/SYN

SYN News

New Syndigo Report: 75% of Consumers Now Judge Brands Based on Availability of Product Information When Shopping Online, an Increase over Prior Years

SYN

CHICAGO--(BUSINESS WIRE)--Syndigo, a global leader in end-to-end Product Experience Management (PXM) solutions, today released its third annual consumer study of brand perceptions based on online product listings and in-store merchandising. The 2025 State of Product Experience report revealed that three in four (75%) consumers form negative opinions about a brand if they encounter incomplete or inaccurate product information online, up from 62% in 2023 and 73% in 2024. This finding underscores

June 11, 2025Research
Read more →

Synthetic Biologics has received a Notice of Allowance for its US patent application 17/314,583 titled 'E. COLI-BASED PRODUCTION OF BETA-LACTAMASE (FOR MICROBIOME-PROTECTING THERAPY)'. Recent reverse split. - PatentGrants

SYN

September 13, 2022
Read more →

Synthetic Biologics Announces Phase I Study To Evaluate The Safety, Tolerability, And Efficacy Of VCN-01 In Combination With Durvalumab In Subjects With Recurrent/ Metastatic Squamous Cell Carcinoma Of The Head And Neck Was Presented At The ESMO Congress

SYN

September 12, 2022
Read more →

Synthetic Biologics Announces Presentation On VCN-11, A Novel Oncolytic Adenovirus Designed To Evade Neutralizing Antibodies At The Upcoming 25th Annual Meeting Of The American Society Of Gene & Cell Therapy May 16-19

SYN

May 4, 2022
Read more →